会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明申请
    • (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same
    • (2-取代的氧苯基)烷酰胺衍生物,毛发生长促进剂和使用其的外用皮肤组合物
    • US20020052498A1
    • 2002-05-02
    • US09984202
    • 2001-10-29
    • Shiseido Co., Ltd.
    • Koji KobayashiHirotada FukunishiTokuro Iwabuchi
    • C07D241/02C07D243/06
    • C07D295/185A61K8/42A61K8/445A61K8/4926A61K8/494A61Q7/00C07C235/34C07C271/44C07C271/52C07C271/64C07C271/66C07C281/02C07D295/088C07D295/13C07D295/205
    • A (2-substituted oxyphenyl)alkanamide derivative or a salt thereof expressed by the following Formula (I): 1 wherein one of A and B is a hydrocarbon group of C3-30 expressed by R1 and the other is null(CH2)n-NR2R3; Z is nullCOnull or nullCONR6null; R2 and R3 individually represent H, lower alkyl or benzyl, or nullNR2R3 may be a heterocycle having 3-7 members; wherein nullCONR5null(CH2)nnullNR2R3 or nullCONR6null(CH2)n-NR2R3 may be the following Group (II): 2 wherein ring Y is a heterocycle of 6 or 7 members; R4 is selected from the group consisting of H, halogen, lower alkyl, lower acyl and etc; R5 and R6 are individually H, lower alkyl, lower acyl or lower alkylcarbamoyl, or may form a part of said Group(II); 1 is 0 or 1; m is 1 or 2; and n is an integer of 0-5. The (2-substituted oxyphenyl)alkanamide derivative or the salt thereof has excellent hair growth and regrowth promoting effects, which are useful for care, improvement or prevention of hair loss in mammals and, in particular, in human.
    • 由下式(I)表示的(2-取代的氧苯基)烷酰胺衍生物或其盐:其中A和B中的一个是由R 3表示的C3-30的烃基,另一个是 - (CH 2)n -NR 2 R 3 ; Z是-CO-或-CONR 6 - ; R2和R3各自表示H,低级烷基或苄基,或-NR2R3可以是具有3-7个成员的杂环; 其中-CONR 5 - (CH 2)n -NR 2 R 3或-CONR 6 - (CH 2)n -NR 2 R 3可以是下列基团(II):其中环Y是6或7个成员的杂环; R4选自H,卤素,低级烷基,低级酰基等; R5和R6各自为H,低级烷基,低级酰基或低级烷基氨基甲酰基,或可形成所述组(II)的一部分。 1为0或1; m为1或2; n为0-5的整数。 (2-取代的氧苯基)烷酰胺衍生物或其盐具有优异的毛发生长和再生长促进作用,其可用于哺乳动物,特别是人的护发,改善或预防脱发。
    • 76. 发明授权
    • 5-Amino or substituted amino-7-phenyl or substituted
phenyl-2,3-dihydro-1H-1,4-diazepines
    • 5-氨基或取代的氨基-7-苯基或取代的苯基-2,3-二氢-1H-1,4-二氮杂
    • US4096140A
    • 1978-06-20
    • US725440
    • 1976-09-22
    • William R. Simpson
    • William R. Simpson
    • C07D243/08C07D401/04C07D403/04C07D405/10C07D243/06A61K31/55
    • C07D401/04C07D243/08C07D403/04C07D405/10Y10S514/866Y10S514/909
    • Compounds of the formula ##STR1## WHEREIN R.sub.1 is hydrogen, alkyl of 1 to 6 carbon atoms or amino, R.sub.2 is hydrogen or alkyl of 1 to 6 carbon atoms, with the provisos that (1) at least one of R.sub.1 and R.sub.2 is not a tertiary alkyl group and (2) R.sub.2 is hydrogen when R.sub.1 is amino, orR.sub.1 and R.sub.2 taken together and with the nitrogen atom to which they are joined are pyrrolidino, piperidino or N'-2-hydroxyethylpiperazino,Each X' is independently alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halo, or two X's on adjacent carbon atoms together are methylenedioxy, andn is 0, 1, 2 or 3,And the pharmaceutically acceptable acid addition salts thereof,Are useful as anti-obesity and anti-diabetic agents. The compounds wherein R.sub.1 is alkyl and R.sub.2 is hydrogen are synthesized by a two-step synthesis from 2-alkyl-5-arylisoxazolium salts and ethylenediamine. The compounds wherein R.sub.1 and R.sub.2 are hydrogen are synthesized by cleaving the t-butyl group from the corresponding compounds wherein R.sub.1 is t-butyl and R.sub.2 is hydrogen. The compounds wherein R.sub.1 is amino are synthesized from the corresponding compounds wherein R.sub.1 is hydrogen or alkyl. All of the compounds are synthesized by reacting ammonia, a suitable amine or hydrazine with a compound of the formula ##STR2## WHEREIN R' is primary or secondary alkyl of 1 to 4 carbon atoms.
    • 下式的化合物,其中R 1为氢,1至6个碳原子的烷基或氨基,R 2为氢或1至6个碳原子的烷基,条件是(1)R 1和R 2中的至少一个不为 叔烷基和(2)当R 1是氨基时,R 2是氢,或者R 1和R 2与它们连接的氮原子一起是吡咯烷子基,哌啶子基或N'-2-羟乙基哌嗪基,每个X'独立地是烷基 1至4个碳原子的烷氧基或1至4个碳原子的烷氧基或卤素,或相邻碳原子上的两个X一起是亚甲二氧基,N IS 0,1,2或3,并且其药学上可接受的酸加法盐,有用 作为抗生素和抗糖尿病药物。 其中R1是烷基,R2是氢的化合物是通过2-烷基-5-芳基异恶唑鎓盐和乙二胺的两步合成来合成的。 其中R1和R2是氢的化合物是通过从相应的化合物中分离出叔丁基来合成的,其中R 1是叔丁基,R 2是氢。 其中R 1为氨基的化合物由相应的化合物合成,其中R1为氢或烷基。 所有这些化合物都是通过氨,合适的胺或肼与下式化合物的反应来合成的:其中R 1是具有1-4个碳原子的伯或仲烷基。